PROVIDER PROFILE · NPI 1952616948
Suzanne MeranD.O.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
6,774
Unique beneficiaries
—
Total services
11,016
Distinct HCPCS
37
Medicare payment
$954K
Peer benchmark
Total Medicare services vs. 1,045 Dermatology providers in FL — top quintile (cohort median 3,561).
PRESCRIBING · PART D · 2024
Total Rx claims
896
Beneficiaries
—
Total drug cost
$56K
Distinct drugs
19
Brand share
18.6%
Top prescribed drugs
Triamcinolone Acetonide131 claims
Doxycycline Monohydrate109 claims
Mupirocin81 claims
Hydrocortisone69 claims
Clotrimazole/Betamethasone Dip65 claims
QUALITY · MIPS · 2024
Final MIPS score
91.8
Quality
93.6
Cost
79.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.71%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$746
Payment records
31
By payment type
Food and Beverage$746
Top paying entities
Food and Beverage$746
REFERRAL NETWORK
Where Suzanne Meran's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Robb Wilentz Pathology · Aventura, FL | 35 | 63 |
| Daniel Rivlin Dermatology · Miami Beach, FL | 27 | 55 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE